UARF
  • Home
  • About Us
    • Licensing
    • Internships
    • Giveaway
  • Programs
    • Starting Line
    • I-Corps
    • Spark Fund
    • STRIDE
    • ARCHAngels
    • Startup Support
    • Legal Support
  • Portfolio
  • Blog
  • News
  • Home
  • About Us
    • Licensing
    • Internships
    • Giveaway
  • Programs
    • Starting Line
    • I-Corps
    • Spark Fund
    • STRIDE
    • ARCHAngels
    • Startup Support
    • Legal Support
  • Portfolio
  • Blog
  • News
Search

The
   Entrepreneur Files

​A UARF weekly blog series featuring articles written from the UARF team members.

Learn about new ideas, business tips, and hear our personal stories about 
the things we learned from you, the entrepreneurs!
Scroll down for the latest article!

One of our largest technology transfer   agreements signed with 21MedTech

1/30/2018

1 Comment

 
From the UA Digest
Two degradable polymer platforms, developed for regenerative medicine and 3D printing, have been exclusively licensed by 21MedTech from the University of Akron Research Foundation. The technologies originate from the Laboratory of Dr. Matthew Becker, a widely recognized scholar and innovator in organic polymer chemistry and biomaterials. He is the W. Gerald Austen Endowed Chair of Polymer Science and Polymer Engineering here. ​
Picture
The proprietary technologies include unique degradable amino acid-based poly(ester urea)s and functional poly(propylene fumarate)s. The licensing terms, which were not disclosed, include upfront royalty payments, sponsored research and ongoing royalties. At its onset, the deal represents one of the most significant licensing arrangements by the University in its 148-year history.
Both UA and 21MedTech have ongoing research in the applications of these technologies in drug delivery and resorbable medical devices. The parties recently were awarded a $2 million grant from Ohio Third Frontier for a non-opioid postoperative pain therapy.
“It’s particularly rewarding to see the translation of our fundamental research into therapies and devices designed to help people in such a vast number of indications,” says Becker. “These are disruptive technologies and we are pleased to be working with the medical device and pharmaceutical veterans at 21MedTech.” 
1 Comment
Daisy Auden link
3/31/2020 12:12:40 am

First of all, we are very thankful for your article. It is very happy to share the feelings that your article is very helpful to people to gain knowledge in the field of Chemistry. We suggest you go through our article where it also helps you as well as others.

Reply



Leave a Reply.

    Categories

    All
    Communication
    Entrepreneurship
    Funding
    Goals And Achievements
    Guide For Students
    Insight
    Interviews
    Marketing
    Productivity And Organization
    Success Stories

    RSS Feed

PROGRAMS

Starting Line
I-Corps
ARCHAngels
STRIDE

COMPANY

About
Contact
Blog
News
411 Wolf Ledges Pkwy, Suite 208
​Akron, OH 44311
© COPYRIGHT 2018 UARF. ALL RIGHTS RESERVED.
  • Home
  • About Us
    • Licensing
    • Internships
    • Giveaway
  • Programs
    • Starting Line
    • I-Corps
    • Spark Fund
    • STRIDE
    • ARCHAngels
    • Startup Support
    • Legal Support
  • Portfolio
  • Blog
  • News